197 related articles for article (PubMed ID: 26195629)
21. Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity.
Rabault B; Ghysdael J
J Biol Chem; 1994 Nov; 269(45):28143-51. PubMed ID: 7961750
[TBL] [Abstract][Full Text] [Related]
22. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
[TBL] [Abstract][Full Text] [Related]
23. Mechanistic heterogeneity in site recognition by the structurally homologous DNA-binding domains of the ETS family transcription factors Ets-1 and PU.1.
Wang S; Linde MH; Munde M; Carvalho VD; Wilson WD; Poon GM
J Biol Chem; 2014 Aug; 289(31):21605-16. PubMed ID: 24952944
[TBL] [Abstract][Full Text] [Related]
24. Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif.
Nye JA; Petersen JM; Gunther CV; Jonsen MD; Graves BJ
Genes Dev; 1992 Jun; 6(6):975-90. PubMed ID: 1592264
[TBL] [Abstract][Full Text] [Related]
25. Multiple DNA-binding modes for the ETS family transcription factor PU.1.
Esaki S; Evich MG; Erlitzki N; Germann MW; Poon GMK
J Biol Chem; 2017 Sep; 292(39):16044-16054. PubMed ID: 28790174
[TBL] [Abstract][Full Text] [Related]
26. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
27. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
[TBL] [Abstract][Full Text] [Related]
28. Structures of the Ets Protein DNA-binding Domains of Transcription Factors Etv1, Etv4, Etv5, and Fev: DETERMINANTS OF DNA BINDING AND REDOX REGULATION BY DISULFIDE BOND FORMATION.
Cooper CD; Newman JA; Aitkenhead H; Allerston CK; Gileadi O
J Biol Chem; 2015 May; 290(22):13692-709. PubMed ID: 25866208
[TBL] [Abstract][Full Text] [Related]
29. The affinity of Ets-1 for DNA is modulated by phosphorylation through transient interactions of an unstructured region.
Lee GM; Pufall MA; Meeker CA; Kang HS; Graves BJ; McIntosh LP
J Mol Biol; 2008 Oct; 382(4):1014-30. PubMed ID: 18692067
[TBL] [Abstract][Full Text] [Related]
30. The biology of the Ets1 proto-oncogene.
Dittmer J
Mol Cancer; 2003 Aug; 2():29. PubMed ID: 12971829
[TBL] [Abstract][Full Text] [Related]
31. Cooperative interaction between ETS1 and GFI1 transcription factors in the repression of Bax gene expression.
Nakazawa Y; Suzuki M; Manabe N; Yamada T; Kihara-Negishi F; Sakurai T; Tenen DG; Iwama A; Mochizuki M; Oikawa T
Oncogene; 2007 May; 26(24):3541-50. PubMed ID: 17213822
[TBL] [Abstract][Full Text] [Related]
32. Modulation of transcription factor Ets-1 DNA binding: DNA-induced unfolding of an alpha helix.
Petersen JM; Skalicky JJ; Donaldson LW; McIntosh LP; Alber T; Graves BJ
Science; 1995 Sep; 269(5232):1866-9. PubMed ID: 7569926
[TBL] [Abstract][Full Text] [Related]
33. Crystallization and preliminary X-ray analysis of a complex of the FOXO1 and Ets1 DNA-binding domains and DNA.
Choy WW; Datta D; Geiger CA; Birrane G; Grant MA
Acta Crystallogr F Struct Biol Commun; 2014 Jan; 70(Pt 1):44-8. PubMed ID: 24419615
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of an intrinsically disordered region of Ets1 shifts a multi-modal interaction ensemble to an auto-inhibitory state.
Kasahara K; Shiina M; Higo J; Ogata K; Nakamura H
Nucleic Acids Res; 2018 Mar; 46(5):2243-2251. PubMed ID: 29309620
[TBL] [Abstract][Full Text] [Related]
35. Identification of an enhancer of the human activating protein-2alpha gene that contains a critical Ets1 binding site.
Cheng YH; Handwerger S
J Clin Endocrinol Metab; 2003 Jul; 88(7):3305-11. PubMed ID: 12843180
[TBL] [Abstract][Full Text] [Related]
36. Identification of a Ets1 variant protein unaffected in its chromatin and in vitro DNA binding capacities by T cell antigen receptor triggering and intracellular calcium rises.
Pognonec P; Boulukos KE; Bosselut R; Boyer C; Schmitt-Verhulst AM; Ghysdael J
Oncogene; 1990 Apr; 5(4):603-10. PubMed ID: 2183162
[TBL] [Abstract][Full Text] [Related]
37. Structural inferences of the ETS1 DNA-binding domain determined by mutational analysis.
Mavrothalassitis G; Fisher RJ; Smyth F; Watson DK; Papas TS
Oncogene; 1994 Feb; 9(2):425-35. PubMed ID: 8290254
[TBL] [Abstract][Full Text] [Related]
38. Sequence specific DNA binding of Ets-1 transcription factor: molecular dynamics study on the Ets domain--DNA complexes.
Obika S; Reddy SY; Bruice TC
J Mol Biol; 2003 Aug; 331(2):345-59. PubMed ID: 12888343
[TBL] [Abstract][Full Text] [Related]
39. Correction of the NMR structure of the ETS1/DNA complex.
Werner MH; Clore GM; Fisher CL; Fisher RJ; Trinh L; Shiloach J; Gronenborn AM
J Biomol NMR; 1997 Dec; 10(4):317-28. PubMed ID: 9460239
[TBL] [Abstract][Full Text] [Related]
40. Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ETS transcription factors and JUN-FOS at composite DNA sites.
Madison BJ; Clark KA; Bhachech N; Hollenhorst PC; Graves BJ; Currie SL
J Biol Chem; 2018 Nov; 293(48):18624-18635. PubMed ID: 30315111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
